Laxana

Laxana may be available in the countries listed below.

Ingredient matches for Laxana

Bisacodyl

Bisacodyl is reported as an ingredient of Laxana in the following countries:

• Indonesia

International Drug Name Search

Prevotec

Prevotec may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Prevotec

Benzylpenicillin

Benzylpenicillin benzathine (a derivative of Benzylpenicillin) is reported as an ingredient of Prevotec in the following countries:

• Switzerland

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Prevotec in the following countries:

• Switzerland

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Prevotec in the following countries:

• Switzerland

International Drug Name Search

Pamoxan

Pamoxan may be available in the countries listed below.

Ingredient matches for Pamoxan

Pyrvinium

Pyrvinium Pamoate is reported as an ingredient of Pamoxan in the following countries:

• Spain

International Drug Name Search

Digitoxin

In the US, Digitoxin is a member of the drug class inotropic agents.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01AA04

CAS registry number (Chemical Abstracts Service)

0000071-63-6

Chemical Formula

C41-H64-O13

Molecular Weight

764

Therapeutic Category

Cardiac glycoside

Chemical Name

3beta-[O4-(O4-beta-D-Digitoxopyranosyl-beta-D-digitoxopyranosyl)-beta-D-digitoxopyranosyloxy]-14-hydroxy-5beta,14beta-card-20(22)-enolid

Foreign Names

• Digitoxinum (Latin)
• Digitoxin (German)
• Digitoxine (French)
• Digitoxina (Spanish)

Generic Names

• Digitaline (OS: DCF)
• Digitossina (OS: DCIT)
• Digitoxin (OS: JAN, BAN)
• Digitoxine (OS: DCF)
• Digitoxoside (IS)
• Digitoxin (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)
• Digitoxine (PH: Ph. Eur. 6)
• Digitoxinum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Digimed
  Corax, Germany



• Digimerck
  Merck, Austria; Merck, Germany; Merck, Hungary



• Digitaline Nativelle
  Procter & Gamble, Luxembourg



• Digitossina
  Salf, Italy



• Digitoxin AWD
  AWD.pharma, Germany



• Digitoxin
  Nycomed, Norway; UCB Pharma, United Kingdom



• Digitoxin-Philo
  Mibe, Germany

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Dimetapp

Generic Name: brompheniramine and phenylpropanolamine (brome feh NEER a meen/fen ill proe pa NO la meen)

Brand Names: Altatapp, Dibrom, Dibromm, Dimaphen, Dimetapp, Myphetapp

What is brompheniramine and phenylpropanolamine?

Brompheniramine is an antihistamine. It works against the naturally occurring chemical histamine in your body. Brompheniramine prevents sneezing; itchy, watery eyes and nose; and other symptoms of allergies and hay fever.

Phenylpropanolamine is a decongestant. It constricts (shrinks) blood vessels (veins and arteries). This reduces the blood flow to certain areas and allows nasal passages to open up.

Brompheniramine and phenylpropanolamine is used to treat nasal congestion and sinusitis (inflammation of the sinuses) associated with allergies, hay fever, and the common cold.

Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.

Brompheniramine and phenylpropanolamine may also be used for purposes other than those listed in this medication guide.

What is the most important information I should know about brompheniramine and phenylpropanolamine?

Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.

Use caution when driving, operating machinery, or performing other hazardous activities. Brompheniramine and phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking brompheniramine and phenylpropanolamine.

Do not take more of this medication than is recommended. If your symptoms do not improve, or if they worsen, talk to your doctor.

What should I discuss with my healthcare provider before taking brompheniramine and phenylpropanolamine?

Do not take brompheniramine and phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Before taking this medication, tell your doctor if you have

• kidney disease,


• liver disease,


• 
  

  diabetes,

  
  


• 
  

  glaucoma,

  
  


• 
  

  any type of heart disease or high blood pressure,

  
  


• 
  

  thyroid disease,

  
  


• 
  

  emphysema or chronic bronchitis, or

  
  


• 
  

  difficulty urinating or an enlarged prostate.

  
  

You may not be able to take brompheniramine and phenylpropanolamine, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.

Brompheniramine and phenylpropanolamine is in the FDA pregnancy category B. This means that it is unlikely to harm an unborn baby. Do not take this medication without first talking to your doctor if you are pregnant. This medication passes into breast milk and may harm a nursing baby. Do not take this medication without first talking to your doctor if you are breast-feeding a baby. If you are over 60 years of age, you may be more likely to experience side effects from brompheniramine and phenylpropanolamine. You may require a lower dose of this medication. Read the package label for directions or consult your doctor or pharmacist before treating a child with this medication. Children are more susceptible than adults to the effects of medicines and may have unusual reactions.

How should I take brompheniramine and phenylpropanolamine?

Take brompheniramine and phenylpropanolamine exactly as directed. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.

Take each dose with a full glass of water. Do not crush, chew, or break the long-acting or sustained-release forms of this medication. Swallow them whole. If you are unsure about the formulation of the medicine, ask your pharmacist for help.

If you cannot swallow the tablets or capsules, look for a liquid form of the medication.

To ensure that you get a correct dose, measure the liquid form of brompheniramine and phenylpropanolamine with a special dose-measuring spoon or cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.

Do not take more of this medication than is recommended. An overdose of this medication can cause serious harm.

Do not take brompheniramine and phenylpropanolamine for longer than 7 days in a row. If your symptoms do not improve, if they get worse, or if you have a fever, talk to your doctor.

Store brompheniramine and phenylpropanolamine at room temperature away from moisture and heat.

What happens if I miss a dose?

Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication.

What happens if I overdose?

Seek emergency medical attention.

Symptoms of a brompheniramine and phenylpropanolamine overdose include a dry mouth, large pupils, flushing, nausea, and vomiting.

What should I avoid while taking brompheniramine and phenylpropanolamine?

Use caution when driving, operating machinery, or performing other hazardous activities. Brompheniramine and phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking brompheniramine and phenylpropanolamine.

Brompheniramine and phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine and phenylpropanolamine is taken with any of these medications.

Brompheniramine and phenylpropanolamine side effects

Serious side effects are unlikely to occur. Stop taking brompheniramine and phenylpropanolamine and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).

Other, less serious side effects may be more likely to occur. Continue to take brompheniramine and phenylpropanolamine and talk to your doctor or try another similar medication if you experience

• 
  

  dryness of the eyes, nose, and mouth;

  
  


• 
  

  drowsiness or dizziness;

  
  


• 
  

  blurred vision;

  
  


• 
  

  difficulty urinating; or

  
  


• 
  

  excitation in children.

  
  

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.

What other drugs will affect brompheniramine and phenylpropanolamine?

Do not take brompheniramine and phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Do not take other over-the-counter cough, cold, allergy, diet, or sleep aids while taking brompheniramine and phenylpropanolamine without first talking to your doctor or pharmacist. Other medications may also contain brompheniramine, phenylpropanolamine, or other similar drugs. You may accidentally take too much of these medicines.

Brompheniramine and phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine and phenylpropanolamine is taken with any of these medications.

Drugs other than those listed here may also interact with brompheniramine and phenylpropanolamine. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.

More Dimetapp resources

• Dimetapp Drug Interactions
• Dimetapp Support Group
• 0 Reviews for Dimetapp - Add your own review/rating

Compare Dimetapp with other medications

• Cold Symptoms

Where can I get more information?

• Your pharmacist has additional information about brompheniramine and phenylpropanolamine written for health professionals that you may read.

What does my medication look like?

Many formulations of brompheniramine and phenylpropanolamine are available both over-the-counter and with a prescription. Ask your pharmacist any questions you have about this medication, especially if it is new to you.

Amilorid comp.-ratiopharm

Amilorid comp.-ratiopharm may be available in the countries listed below.

Ingredient matches for Amilorid comp.-ratiopharm

Amiloride

Amiloride hydrochloride dihydrate (a derivative of Amiloride) is reported as an ingredient of Amilorid comp.-ratiopharm in the following countries:

• Germany

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Amilorid comp.-ratiopharm in the following countries:

• Germany

International Drug Name Search

Toragamma

Toragamma may be available in the countries listed below.

Ingredient matches for Toragamma

Torasemide

Torasemide is reported as an ingredient of Toragamma in the following countries:

• Germany

International Drug Name Search